Gradient Denervation Technologies
PrivateLast Round
Series A
Sep 7, 2023
Total Funding Raised
$19.15M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Gradient Denervation Technologies operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Series A round in September 2023.
Gradient Denervation Technologies is a medical device company developing a minimally invasive, ultrasound-based device for the treatment of pulmonary hypertension.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gradient Denervation Technologies Comparables
Compare Gradient Denervation Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cortex, Inc. | 88% | |
| Pulnovo Medical | 85% | |
| PULNOVO | 83% |
For institutional investors. Book with your work email.
Gradient Denervation Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 7, 2023 | ||||
| Seed | Sep 17, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Gradient Denervation Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asabys Partners | Series A |
| Thuja Capital | Series A |
| Sofinnova Partners | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 4, 2.5x the trailing average.
- May 20, 2026
Grew 19% QoQ, from 16 to 19 employees.
For institutional investors. Book with your work email.
Gradient Denervation Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Gradient Denervation Technologies's valuation, stock price, and market status.
Is Gradient Denervation Technologies a public or private company?
Gradient Denervation Technologies is a private company.
What is the current stock price of Gradient Denervation Technologies?
Gradient Denervation Technologies is a private company, so its shares have no public market price. Caplight tracks Gradient Denervation Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Gradient Denervation Technologies worth (valuation)?
Valuation information for Gradient Denervation Technologies is not publicly available.
Can I buy Gradient Denervation Technologies stock?
Gradient Denervation Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Gradient Denervation Technologies's last funding round?
Gradient Denervation Technologies's most recent funding round was Series A on September 7, 2023.
Who are the main investors in Gradient Denervation Technologies?
Key investors in Gradient Denervation Technologies include Asabys Partners, Sofinnova Partners.
Will Gradient Denervation Technologies IPO soon?
No public IPO plans have been announced for Gradient Denervation Technologies.
How can I track Gradient Denervation Technologies secondary market activity?
Caplight tracks bids, offers, and trades in Gradient Denervation Technologies's shares on secondary markets.